Palma Rocchi is the Directrice de l’Unité Inserm ERL U1326 “RNAnoTher,” focusing on mRNA, nanomedicine, and theranostic approaches to personalized therapy. They have served as a researcher at INSERM since 2006 and as a group leader since 2007. Palma completed a PhD in Biology at Aix-Marseille Université and pursued a postdoctoral fellowship in Oncology and Cancer Biology at The University of British Columbia. Currently, Palma is also a co-founder and Chief Scientific Officer at Silon Therapeutics, a role they began in 2024.
This person is not in the org chart
This person is not in any teams
This person is not in any offices